ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 305222 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 305222; 2) Community: the network communities that were significantly associated with the response to NSC 305222; 3) Molecule: the relationships between components within communities and NSC 305222; 4) MDR: the compounds that were significantly associated with the NSC 305222.

NSC Compound Enrichment Correlation
NSC 751295 diaporthein B 0.0410413740044188 -0.12638596
NSC 756158 GSK237700A 0.0410413740044188 -0.060161059
NSC 764135 BMS-599626 0.0410413740044188 0.089837156
NSC 76919 2-Pyridinecarboxylic acid, 5-amino-6-(7-amino-1,2,3,4,5,8-hexahydro- 5,8-dioxo-2-quinolinyl)-4-(2-hydroxy- 3,4-dimethoxyphenyl)-3-methyl- 0.0410413740044188 0.098871701
NSC 80466 1H-Naphth[2,3-d]imidazolium, 4,9-dihydro-1,2-dimethyl-3-(2-methylpropyl)-4,9-dioxo-, iodide 0.0410413740044188 -0.1051741
NSC 85700 Quinolinium, 2-[2-(8-hydroxy-5-quinolyl)vinyl]-1,6-methyl-, iodide (8CI) 0.0410413740044188 0.052396823
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.0420420371076614 -0.19006494
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.0420420371076614 -0.11621326
NSC 256927 CHIP 0.0420420371076614 -0.084095005
NSC 295501 Camptothecin Derivative 0.0420420371076614 0.25321709
Total:61  Current:47    [First] [Prev] [Next] [Last]